CG MedTech Co.Ltd. · KRX:056090

CG MedTech Co.Ltd. financial statements

CG MedTech Co.Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue47.2B34.6B35.0B41.2B38.1B27.8B34.8B31.7B13.3B11.7B
Cost of revenue26.1B18.5B16.7B22.1B22.2B21.6B21.1B20.8B9.13B5.32B
Gross profit21.2B16.1B18.3B19.1B15.9B6.18B13.7B10.8B4.16B6.37B
Research and development3.76B3.36B4.46B4.47B4.33B3.88B3.25B3.12B
Selling, general and administrative7.57B6.92B7.45B6.63B10.9B11.9B9.94B10.5B5.89B6.07B
Operating income3.82B-1.10B3.06B404.6M-5.08B-10.8B-1.13B-15.2B-5.34B-3.19B
Depreciation and amortization2.26B1.69B1.85B2.20B1.74B2.41B2.25B2.83B1.68B762.6M
EBITDA6.08B596.1M4.91B2.61B-3.35B-8.40B1.11B-12.4B-3.66B-2.42B
Interest expense176.3M185.7M535.9M6.32B00000
Income before tax2.74B12.9M1.39B-18.4B-5.41B-12.1B-1.79B-15.9B-6.32B-2.12B
Income tax175.0M100.4M-1.19B227.4M-43.5M
Net income6.51B59.7M1.63B-18.5B-4.97B-12.3B-1.89B-14.7B-6.54B-2.08B
Earnings per share, basic63.020.5820.65-235.03-107.93-305.70-49.38-385.65-172.72-54.87

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents10.4B26.9B12.6B22.5B2.57M5.09B3.88B11.0B11.3B6.59B
Short-term investments397.2M7.36B1.70B52.5B7.85B4.75B2.05B4.20B14.3B21.5B
Receivables7.25B5.43B6.52B7.46B6.78B7.19B10.1B6.66B5.80B6.23B
Inventory15.4B12.3B11.5B10.6B10.2B9.20B15.1B14.3B13.1B12.3B
Current assets35.1B54.1B33.6B94.8B39.7B28.0B32.8B36.6B45.6B47.0B
Property, plant and equipment18.0B17.7B20.3B21.3B15.9B13.6B
Goodwill6.65B1.52B2.78B
Total assets114.9B107.2B79.1B141.4B75.1B64.4B71.1B74.9B79.1B66.2B
Accounts payable1.42B2.46B1.48B1.22B1.22B1.46B1.24B1.44B536.5M
Current liabilities16.5B11.9B8.74B72.7B22.3B24.1B9.81B18.2B5.35B4.38B
Long-term debt859.7M1.45B15.2B5.00B17.7B12.7B15.5B1.17B
Total debt6.60B20.9B12.7B16.6B3.17B
Total liabilities20.8B20.4B19.2B83.8B46.5B37.3B33.1B35.7B24.8B7.09B
Shareholders' equity94.0B87.2B60.2B57.7B28.5B27.1B38.0B39.2B54.3B59.1B
Shares outstanding103.3M103.3M78.9M78.9M46.1M40.2M38.3M38.2M37.9M37.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations2.61B1.51B-2.48B-5.36B1.28B2.15B-2.11B-2.95B-1.54B-3.54B
Capital spending-11.9B-810.0M-1.65B-949.8M-862.2M-204.7M-710.8M-15.4B-783.8M-1.00B
Free cash flow-9.33B700.7M-4.12B-6.31B422.5M1.95B-2.82B-18.3B-2.32B-4.55B
Cash from investing-4.65B-1.62B-472.2M-7.44B-9.51B5.16B
Cash from financing10.4B875.1M-4.51B10.0B15.9B-8.06B
Share buybacks476.3M74.0M-1.78B
Change in cash-16.5B14.3B-9.85B10.2B7.25B1.21B-7.12B-347.5M4.76B-6.39B